buy outlook 2010 uk cheap ms office 2010 purchase office 2010 cheap adobe cs3 win buy bento 3 cheap purchase quicken premier 2009 cost of adobe lightroom 2 buy stellar phoenix mac data recovery cheap software microsoft office 2013 cheap server 2003 software buy tiger 10.4.0 mac nuance pdf converter discount windows xp home edition purchase buy visio 2007 price of windows xp original
buying rosetta stone wholesale purchase office 2003 product keys order windows xp sp2 cd buying camtasia purchase microsoft office excel 2007 buy microsoft office 07 purchase windows xp professional upgrade windows 7 full academic discount purchase money 2008 best price pinnacle studio ultimate collection best buy photoshop cs6 student buying 2007 microsoft office microsoft office 2013 academic discount adobe audition purchase cheap excel 2010

Enhanced radiation sensitivity in HPV-positive head and neck cancer

Mon, Jun 10, 2013

Oral Cancer News

Source: http://cancerres.aacrjournals.org
Authors: 
Randall J. Kimple1,*,Molly A. Smith1,Grace C Blitzer1,Alexandra D Torres1,Joshua A Martin1,Robert Z. Yang1,Chimera R Peet1,Laurel D. Lorenz2,Kwangok P Nickel3,Aloysius J Klingelhutz4,Paul F Lambert5, andPaul M Harari1

 

Abstract

Patients with human papillomavirus associated (HPV+) head and neck cancer (HNC) demonstrate significantly improved survival outcome compared to those with HPV-negative (HPV-) tumors. Published data examining this difference offers conflicting results to date. We systematically investigated the radiation sensitivity of all available validated HPV+ HNC cell lines and a series of HPV- HNC cell lines using in vitro and in vivo techniques. HPV+ HNCs exhibited greater intrinsic radiation sensitivity (average SF2 HPV- 0.59 vs. HPV+ 0.22, p<0.0001), corresponding with a prolonged G2/M cell cycle arrest and increased apoptosis following radiation exposure (percent change 0% vs. 85%, p=0.002). A genome-wide microarray was used to compare gene-expression 24 hours following radiation between HPV+ and HPV- cell lines. Multiple genes in TP53 pathway were upregulated in HPV+ cells (Z score 4.90), including a 4.6 fold increase in TP53 (p<0.0001). Using immortalized human tonsillar epithelial cells, increased radiation sensitivity was seen in cell expressing HPV-16 E6 despite the effect of E6 to degrade p53. This suggested that low levels of normally functioning p53 in HPV+ HNC cells could be activated by radiation, leading to cell death. Consistent with this, more complete knockdown of TP53 by siRNA resulted in radiation resistance. These results provide clear evidence, and a supporting mechanism, for increased radiation sensitivity in HPV+ HNC relative to HPV- HNC. This issue is under active investigation in a series of clinical trials attempting to de-escalate radiation (and chemotherapy) in selected patients with HPV+ HNC in light of their favorable overall survival outcome.

• Received February 28, 2013.
• Revision received April 9, 2013.
• Accepted April 26, 2013.
 

• Copyright © 2013, American Association for Cancer Research.

 

*This news story was resourced by the Oral Cancer Foundation, and vetted for appropriateness and accuracy.

 

Print Friendly
Be Sociable, Share!
, , , ,

Leave a Reply

You must be logged in to post a comment.